Drug Use For Unknown Indication |
28.0% |
Pneumonia |
9.1% |
Pyrexia |
7.5% |
Bronchopulmonary Aspergillosis |
7.0% |
Acute Lymphocytic Leukaemia |
4.8% |
Febrile Neutropenia |
4.8% |
Infection |
4.8% |
Mycobacterium Avium Complex Infection |
4.3% |
Prophylaxis |
4.3% |
Keratitis |
3.8% |
Infection Prophylaxis |
3.2% |
Unrelated Donor Bone Marrow Transplantation Therapy |
3.2% |
Aspergillosis |
2.2% |
Oesophageal Infection |
2.2% |
Prophylaxis Against Graft Versus Host Disease |
2.2% |
Sepsis |
2.2% |
Systemic Lupus Erythematosus |
2.2% |
Acute Promyelocytic Leukaemia |
1.6% |
Chronic Obstructive Pulmonary Disease |
1.6% |
Acute Monocytic Leukaemia |
1.1% |